AU7719596A - Adenovirus-mediated production of bioactive proteins by mammalian cells and animals - Google Patents

Adenovirus-mediated production of bioactive proteins by mammalian cells and animals

Info

Publication number
AU7719596A
AU7719596A AU77195/96A AU7719596A AU7719596A AU 7719596 A AU7719596 A AU 7719596A AU 77195/96 A AU77195/96 A AU 77195/96A AU 7719596 A AU7719596 A AU 7719596A AU 7719596 A AU7719596 A AU 7719596A
Authority
AU
Australia
Prior art keywords
adenovirus
animals
mammalian cells
bioactive proteins
mediated production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77195/96A
Inventor
Brian Baumgartner
H. David Shine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU7719596A publication Critical patent/AU7719596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU77195/96A 1995-11-07 1996-11-06 Adenovirus-mediated production of bioactive proteins by mammalian cells and animals Abandoned AU7719596A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US660395P 1995-11-07 1995-11-07
US789095P 1995-11-07 1995-11-07
US007890 1995-11-07
US006603 1995-11-07
PCT/US1996/017394 WO1997017090A1 (en) 1995-11-07 1996-11-06 Adenovirus-mediated production of bioactive proteins by mammalian cells and animals

Publications (1)

Publication Number Publication Date
AU7719596A true AU7719596A (en) 1997-05-29

Family

ID=26675837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77195/96A Abandoned AU7719596A (en) 1995-11-07 1996-11-06 Adenovirus-mediated production of bioactive proteins by mammalian cells and animals

Country Status (2)

Country Link
AU (1) AU7719596A (en)
WO (1) WO1997017090A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036486A2 (en) 1999-11-18 2001-05-25 Oxford Biomedica (Uk) Limited Scfv antibodies against disease associated molecules
US7276488B2 (en) 1997-06-04 2007-10-02 Oxford Biomedica (Uk) Limited Vector system
CN1224712C (en) 1997-06-04 2005-10-26 牛津生物医学（英国）有限公司 Vector
EP1109572A4 (en) * 1998-09-03 2004-11-24 Neuronz Ltd Neuroprotection
DE1221490T1 (en) 1999-09-17 2003-05-28 Tgt Lab S A De C V RECOMBINANT, ADENOVIRAL VECTORS, AND ITS USE IN THE TREATMENT OF DIFFERENT TYPES OF LIVER, KIDNEY AND LUNG FIBROSIS AND HYPERTROPHIC STAINING
US7883888B2 (en) * 2000-04-05 2011-02-08 The Research Foundation —The State University of New York Peptides selectively lethal to malignant and transformed mammalian cells
DE10020505A1 (en) * 2000-04-26 2001-10-31 Conzelmann Karl Klaus RSV NS proteins antagonize the interferon (IFN) response
US7112570B2 (en) 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
MXPA00011713A (en) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Re-combining viral and non-viral vectors containing the human gene of the urokinase plasminogen activator and its benefit in the treatment of diverse types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars.
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
EP1401808B1 (en) 2001-05-24 2009-07-08 Neuren Pharmaceuticals Limited Gpe analogs and peptidomimetics
CU23102A1 (en) * 2002-10-21 2005-12-20 Ct Ingenieria Genetica Biotech METHOD FOR THE PRODUCTION OF RECOMBINANT PROTEINS IN THE MAMMARY GLAND OF NON-TRANSGENIC MAMMALS
EP1477567A1 (en) * 2003-05-14 2004-11-17 Axxima Pharmaceuticals AG Method for recombinant production of mammalian proteins and proteins obtainable by such method
WO2004101805A1 (en) * 2003-05-14 2004-11-25 Axxima Pharmaceuticals Ag Method for recombinant production of mammalian proteins and proteins obtainable by such method
CN1869217B (en) * 2006-05-22 2013-08-07 李青旺 Method for producing transgene protein medicine of mammary gland expression using gland virus as carrier mammary

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain

Also Published As

Publication number Publication date
WO1997017090A1 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
AU3936697A (en) Large scale production of human or animal proteins using plant bioreactors
AU7719596A (en) Adenovirus-mediated production of bioactive proteins by mammalian cells and animals
PL323737A1 (en) Method of controlling sialination of proteins produced by cultures of mammals tissue cells
AU6039696A (en) Myogenic differentiation of human mesenchymal stem cells
AU6541990A (en) Extracellular matrix protein adherent t cells
AU6504796A (en) Production of secreted foreign polypeptides in plant cell culture
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
AU1119397A (en) Ex vivo culture of stem cells
AU1406497A (en) Mutational variants of mammalian ob gene proteins
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU3228789A (en) Biologically active proteins
AU2885489A (en) Enzymatic hydrolysis of proteins
AU1089995A (en) Control of cell growth
AU7979098A (en) Complete activation of mammalian oocytes
AU7217194A (en) Transformed mammalian cells capable of expressing cecropin b
AU4257789A (en) Electro-insertion of proteins into animal cell membranes
AU3102289A (en) Regulation of expression in mammalian cells
AU1428892A (en) Method of lyophilization of mammalian sperm cells
AU3823795A (en) Novel mammalian protein associated with uncontrolled cell division
AU6405196A (en) Novel system for multilayer growth of anchorage-dependent cells
AU4629596A (en) Materials and methods relating to the regulation of polypeptide production in cells
AU6756396A (en) Heterologous protein production system using avian cells
AU4935896A (en) Gene expression in mammalian cells
AU2951892A (en) Culture of bone cells
AU7731696A (en) Photosynthetic production of stable isotopically labeled recombinant proteins